A scientific and animal welfare assessment of the OECD Health Effects Test Guidelines for the safety testing of chemicals under the European union REACH system

Alternatives to Laboratory Animals

Volumn 32, Issue 3, 2004, Pages 163-208

  Combes, Robert D ^a   Gaunt, Ian ^a   Balls, Michael ^a  

^a RUSSELL AND BURCH HOUSE   (United Kingdom)

Author keywords

Chemicals testing; OECD Health Effects Test Guidelines; REACH; Testing strategy; Three Rs

Indexed keywords

CHEMICAL COMPOUND;

ANIMAL CARE; ANIMAL HOUSING; ANIMAL RIGHTS; ANIMAL TESTING REFINEMENT; ANIMAL TESTING REPLACEMENT; ANIMAL USE; ANIMAL WELFARE; CHEMICAL ANALYSIS; CONFERENCE PAPER; EUROPEAN UNION; EVALUATION; EXPERIMENTAL ANIMAL; HISTOPATHOLOGY; INTERNET; LAW; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTRATION; SAFETY; SCREENING; TISSUE SLICE; TOXICITY TESTING;

ANIMALIA;

EID: 8744282455     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290403200304     Document Type: Conference Paper

References (148)

1. Anon. (2001). White Paper on a Strategy for a Future Chemicals Policy, COM(2001) 88 final. Website http://europa.eu.int/eur-lex/en/com/wpr/2001/ com2001_0088en01.pdf (Accessed 29.8.04).
2. Auer, C.M. & Fielder, R.J. (1999). Regulation of industrial chemicals in the USA and the European Union. In General and Applied Toxicology, 2nd edn, Vol. 3 (ed. B. Ballantyne, T.C. Marrs & T. Syversen), pp. 1581-1597. Basingstoke, UK: Macmillan Reference.
3. Vogelgesang, J. (2002). The EC White Paper on a Strategy for a Future Chemicals Policy. ATLA 30, Suppl. 2, 211-212.
4. Dandrea, J. & Combes, R.D. (2003). A survey of stakeholder organisations on the proposed new European chemicals policy. ATLA 31, 501-528.
5. Combes, R., Barratt, M. & Balls, M. (2003). An overall strategy for the testing of chemicals for human hazard and risk assessment under the EU REACH system. ATLA 31, 7-19.
6. Combes, R., Dandrea, J. & Balls, M. (2003). A critical assessment of the European Commission's proposals for the risk assessment and registration of chemical substances in the European Union. ATLA 31, 353-364.
7. Worth, A.P. & Balls, M., eds (2002). Alternative (non-animal) methods for chemicals testing: current status and future prospects. A report prepared by ECVAM and the ECVAM Working Group on Chemicals. ATLA 30, Suppl. 1, 1-125.
8. European Commission (2003). Consultation Documents Volumes I-VII Concerning the Registration, Evaluation and Authorisation of Chemicals (REACH). Website http://europa.eu.int/comm/environment/chemicals/whitepaper.htm (Accessed 12.11.03).
9. Langley, G. (2001). The Way Forward - Action to End Animal Toxicity Testing, 36pp. London, UK: BUAV.
10. Anon. (2004). Opinion of the Scientific Committee on Toxicity, Ecotoxicity and the Environment (CSTEE) on the BUAV-ECEAE report on "The Way Forward - Action to End Animal Toxicity Testing", Health & Protection Directorate-General, C7/VR/csteeop/anat/080104 D(04), 20pp. Brussels, Belgium: European Commission.
11. Paine, A.J. & Marrs, T.C. (1999). The design of toxicological studies. In General and Applied Toxicology, 2nd edn, Vol. 1 (ed. B. Ballantyne, T.C. Marrs & T. Syversen), pp. 321-334. Basingstoke, UK: Macmillan Reference.
12. Russell, W.M.S. & Burch, R.L. (1959). The Principles of Humane Experimental Technique, 238pp. London, UK: Methuen. Available on the Universities Federation for Animal Welfare (UFAW) website http://altweb.jhsph. edu/publications/humane_exp/het-toc.htm (Accessed 31.8.04).
13. Balls, M., Goldberg, A.M., Fentem, J.H., Broadhead, C.L., Burch, R.L., Festing, M.F.W., Frazier, J.M., Hendriksen, C.F.M., Jennings, M., van der Kamp, M.D.O., Morton, D.B., Rowan, A.N., Russell, C., Russell, W.M.S., Spielmann, H., Stephens, M.L., Stokes, W.S., Straughan, D.W., Yager, J.D., Zurlo, J. & van Zutphen, B.F.M. (1995). The Three Rs: the way forward. The report and recommendations of ECVAM workshop 11. ATLA 23, 838-866.
14. Festing, M.F.W., Baumans, V., Combes, R.D., Halder, M., Hendriksen, C.F.M., Howard, B.R., Lovell, D.P., Moore, G.J., Overend, P. & Wilson, M.S. (1998). Reducing the use of laboratory animals in biomedical research: problems and possible solutions. The report and recommendations of ECVAM workshop 29. ATLA 26, 283-301.
15. Festing, M.F.W., Overend, P., Gaines Das, R., Cortina Borja, M. & Berdoy, M. (2002). The Design of Animal Experiments: Reducing the Use of Animals in Research Through Better Experimental Design, 112pp. London, UK: Royal Society of Medicine Press.
16. Flecknell, P.A. (1994). Refinement of animal use - assessment and alleviation of pain and distress. Laboratory Animals 28, 222-231.
17. Morris, T., Goulet, S. & Morton, D. (2002). The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for animal care in regulatory toxicology. ILAR Journal 43, Suppl., S123-S125.
18. Myers, R.C. (1999). Animal welfare in the toxicology laboratory. In General and Applied Toxicology, 2nd edn, Vol. 1 (ed. B. Ballantyne, T.C. Marrs & T. Syversen), pp. 485-507. Basingstoke, UK: Macmillan Reference.
19. Smaje, L.H., Smith, J.A., Combes, R.D., Ewbank, R., Gregory, J.A., Jennings, M., Moore, G.J. & Morton, D.B. (1998). Advancing refinement of laboratory animal use. Laboratory Animals 32, 137-142.
20. Combes, R., Schechtman, L., Stokes, W.S. & Blakey, D. (2002). The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for subchronic/chronic toxicity and carcinogenicity testing. ILAR Journal 43, Suppl., S112-S117.
21. Schlede, E., Diener, W. & Gerner, I. (1999). Humane endpoints in toxicity testing. In Humane Endpoints in Animal Experiments for Biomedical Research (ed. C.F.M. Hendriksen & D.B. Morton), pp. 75-78. London, UK: Royal Society of Medicine Press.
22. OECD (2000). Guidance Document on the Recognition, Assessment and Use of Clinical Signs as Humane Endpoints for Experimental Animals used in Safety Evaluation, ENV/JM/MONO(2000)7, 39pp. Paris, France: OECD.
23. Balls, M. (1994). Replacement of animal procedures: alternatives in research, education and testing. Laboratory Animals 28, 193-211.
24. Balls, M. (2002). Future improvements: replacement in vitro methods. ILAR Journal 43, Suppl., S69-S73.
25. Gad, S.C. (1999). Alternatives to in vivo studies in toxicology. In General and Applied Toxicology, 2nd edn, Vol. 1 (ed. B. Ballantyne, T.C. Marrs & T. Syversen), pp. 401-424. Basingstoke, UK: Macmillan Reference.
26. Koeter, H.B.W.M. (1999). The OECD test guidelines programme and animal welfare concern: how to avoid major animal suffering. In Humane Endpoints in Animal Experiments for Biomedical Research (ed. C.F.M. Hendriksen & D.B. Morton), pp. 13-14. London, UK: Royal Society of Medicine Press.
27. Roe, F.J.C. (1993). Influence of animal species, strain, age, hormonal, and nutritional status. In Experimental Toxicology: The Basic Issues, 2nd edn (ed. D. Anderson & D.M. Conning), pp. 23-34. London, UK: Royal Society of Chemistry.
28. Rao, G.N. & Huff, J. (1990). Refinement of long-term toxicity and carcinogenesis studies. Fundamental and Applied Toxicology 15, 33-43.
29. Stephens, M.L., Conlee, K., Alvino, G. & Rowan, A.N. (2002). Possibilities for refinement and reduction: future improvements within regulatory testing. ILAR Journal 43, Suppl., S74-S79.
30. Cook, C. & Thomas, D. (2004). Reducing the invasiveness of obtaining blood-borne measures in animals. ATLA 32, Suppl. 1, 203-207.
31. Baumans, V. (2003). Environmental enrichment does not affect the variability of animal experimentation data in the light/dark test. 3R-Info-Bulletin 22, 1-5. Website http://www.forschung3r.ch/de/publications/ bu22_print.html (Accessed 20.7.04).
32. OECD (1982). Good Laboratory Practice in the Testing of Chemicals. Paris, France: OECD.
33. OECD (1998). Principles of Good Laboratory Practice, 41pp. Paris, France: OECD.
34. Combes, R., Balls, M., Bansil, L., Barratt, M., Bell, D., Botham, P., Broadhead, C., Clothier, R., George, E., Fentem, J., Jackson, M., Indans, I., Loizou, G., Navaratnam, V., Pentreath, V., Phillips, B., Stemplewski, H. & Stewart, J. (2002). An assessment of progress in the use of alternatives in toxicity testing since the publication of the report of the Second FRAME Toxicity Committee (1991). ATLA 30, 365-406.
35. Knight, D.J. & Breheny, D. (2002). Alternatives to animal testing in the safety evaluation of products. ATLA 30, 7-22.
36. Spielmann, H., Balls, M., Brand, M., Döring, B., Holzhütter, H-G., Kalweit, S., Klecak, G., Eplattenier, H.L., Liebsch, M., Lovell, W.W., Maurer, T., Moldenhauer, F., Moore, L., Pape, W.J.W., Pfannenbecker, U., Potthast, J., De Silva, O., Steiling, W. & Willshaw, A. (1994). EEC/COLIPA project on in vitro phototoxicity testing: first results obtained with a Balb/c 3T3 cell phototoxicity assay. Toxicology in Vitro 8, 793-796.
37. Spielmann, H., Balls, M., Dupuis, J., Pape, W.J., Pechovitch, G., de Silva, O., Holzhütter, H-G., Clothier, R., Desolle, P., Gerberick, F., Liebsch, M., Lovell, W.W., Maurer, T., Pfannenbecker, U., Potthast, J.M., Csato, M., Sladowski, D., Steiling, W. & Brantom, P. (1998). The international EU/COLIPA in vitro phototoxicity validation study: results of phase II (blind trial). Part 1: the 3T3 NRU phototoxicity test. Toxicology in Vitro 12, 305-327.
38. Spielmann, H., Balls, M., Dupuis, J., Pape, W.J.W., de Suva, O., Holzhütter, H-G., Gerberick, F., Liebsch, M., Lovell, W.W. & Pfannenbecker, U. (1998). A study on UV filter chemicals from Annex VII of European Union Directive 76/768/EEC, in the in vitro 3T3 NRU phototoxicity test. ATLA 26, 679-708.
39. Spielmann, H. & Liebsch, M. (2002). Validation successes: chemicals. ATLA 30, Suppl. 2, 33-40.
40. Barratt, M.D. & Rodford, R.A (2001). The computational prediction of toxicity. Current Opinion in Chemical Biology 5, 383-388.
41. Kimber, I. (2002). Reduction, refinement and replacement: putting the immune system to work. ATLA 30, 569-577.
42. Kimber, I., Cumberbatch, M., Betts, C.J. & Dearman, R.J. (2004). Dendritic cells and skin sensitisation hazard assessment. Toxicology in Vitro 18, 195-202.
43. Brown, N.A., Spielmann, H., Bechter, R., Flint, O.P., Freeman, S.J., Jelínek, R.J., Koch, E., Nau, H., Newall, D.R., Palmer, A.K., Renault, J-Y., Repetto, M., Vogel, R. & Wiger, R. (1995). Screening chemicals for reproductive toxicity: the current alternatives. The report and recommendations of an ECVAM/ETS workshop (ECVAM workshop 12). ATLA 23, 868-882.
44. Spielmann, H., Pohl, I., Döring, B., Liebsch, M. & Moldenhauer, F. (1997). The embryonic stem cell test (EST), an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Toxicology 10, 119-127.
45. Genschow, E., Scholz, G., Brown, N., Piersma, A., Brady, M., Clemann, N., Huuskonen, H., Paillard, F., Bremer, S., Becker, K. & Spielmann, H. (2000). Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study. In Vitro and Molecular Toxicology 13, 51-66.
46. Genschow, E., Spielmann, H., Scholz, G., Seiler, A., Brown, N., Piersma, A., Brady, M., Clemann, N., Huuskonen, H., Paillard, F., Bremer, S. & Becker, K. (2002). The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. ATLA 30, 151-176.
47. Bremer, S., Pellizzer, C., Adler, S., Paparella, M. & de Lange, J. (2002). Development of a testing strategy for detecting embryotoxic hazards of chemicals in vitro by using embryonic stem cell models. ATLA 30, Suppl. 2, 107-109.
48. Genschow, E., Spielmann, H., Scholz, G., Pohl, I., Seiler, A., Clemann, N., Bremer, S. & Becker, K. (2004). Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA 32, 209-244.
49. Spielmann, H., Genschow, E., Brown, N.A., Piersma, A.H., Verhoef, A., Spanjersberg, M.Q.I., Huuskonen, H., Paillard, F. & Seiler, A. (2004). Validation of the rat limb bud micromass test in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA 32, 245-274.
50. Piersma, A.H., Genschow, E., Verhoef, A., Spanjersberg, M.Q.I., Brown, N.A., Brady, M., Burns, A., Clemann, N., Seiler, A. & Spielmann, H. (2004). Validation of the postimplantation rat whole-embryo culture test in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA 32, 275-307.
51. Botham, P.A., Earl, L.K., Fentem, J.H., Roguet, R. & van der Sandt, J.J.M. (1998). Alternative methods for skin irritation testing: the current status. ECVAM Skin Irritation Task Force report 1. ATLA 26, 195-211.
52. Fentem, J.H., Briggs, D., Chesné, C., Elliott, G.R., Harbell, J.W., Heylings, J.R., Portes, P., Roguet, R., van de Sandt, J.J.M. & Botham, P.A. (2001). A prevalidation study on in vitro tests for acute skin irritation: results and evaluation by the management team. Toxicology in Vitro 15, 57-93.
53. Heylings, J.R., Diot, S., Esdaile, D.J., Fasano, W.J., Manning, L.A. & Owen, H.M. (2003). A prevalidation study on the in vitro skin irritation function test (SIFT) for prediction of acute skin irritation in vivo: results and evaluation of ECVAM Phase III. Toxicology in Vitro 17, 123-138.
54. Portes, P., Grandidier, M-H., Cohen, C. & Roguet, R. (2002). Refinement of the Episkin® protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study. Toxicology in Vitro 16, 765-770.
55. van de Sandt, J., Roguet, R., Cohen, C., Esdaile, D., Ponec, M., Corsini, E., Barker, C., Fusenig, N., Liebsch, M., Benford, D., de Brugerolle de Fraissinette, A. & Fartasch, M. (1999). The use of human keratinocytes and human skin models for predicting skin irritation. The report and recommendations of ECVAM workshop 38. ATLA 27, 723-743.
56. Zuang, V., Balls, M., Botham, P.A., Coquette, A., Corsini, E., Gurren, R.D., Elliott, G.R., Fentem, J.H., Heylings, J.R., Liebsch, M., Medina, J., Roguet, R., van de Sandt, J.J.M., Wiemann, C. & Worth, A.P. (2002). Follow-up to the ECVAM prevalidation study on in vitro tests for acute skin irritation. ATLA 30, 109-129.
57. Fentem, J.H. & Botham, P.A. (2002). ECVAM's activities in validating alternative tests for skin corrosion and irritation. ATLA 30, Suppl. 2, 61-67.
58. Fentem, J.H., Archer, G.E.B., Balls, M., Botham, P.A., Curren, R.D., Earl, L.K., Esdaile, D.J., Holzhütter, H-G. & Liebsch, M. (1998). The ECVAM international validation study on in vitro tests for skin corrosivity. 2. Results and evaluation by the management team. Toxicology in Vitro 12, 483-524.
59. Garle, M.J. & Fry, J.R. (2003). Sensory nerves, neurogenic inflammation and pain: missing components of alternative irritation strategies? A review and a potential strategy. ATLA 31, 295-316.
60. Worth, A.P. & Cronin, M.T.D. (2001). Prediction models for eye irritation potential based on endpoints of the HET-CAM and neutral red uptake assays. In Vitro and Molecular Toxicology 14, 143-156.
61. Moldenhauer, F. (2003). Using in vitro prediction models instead of the rabbit eye irritation test to classify and label new chemicals: a post hoc data analysis of the international EC/HO validation study. ATLA 31, 31-46.
62. Curren, R.D. & Harbell, J.W. (2002). Ocular safety: a silent (in vitro) success story. ATLA 30, Suppl. 2, 69-74.
63. Gautheron, P., Giroux, J., Cottin, M., Audegond, L., Morilla, A., Mayordomo-Blanco, L., Tortajada, A., Haynes, G., Vericat, J.A., Pirovano, R., Gillio Tos, E., Hagemann, C., Vanparys, P., Deknudt, G., Jacobs, G., Prinsen, M., Kaiweit, S. & Spielmann, H. (1994). Intel-laboratory assessment of the bovine corneal opacity and permeability (BCOP) assay. Toxicology in Vitro 8, 381-392.
64. Bruner, L.H., de Silva, O., Earl, L.K., Easty, D.L., Pape, W. & Spielmann, H. (1998). Report on the COLIPA workshop on mechanisms of eye irritation. ATLA 26, 811-820.
65. Cooper, K.J., Earl, L.K., Harbell, J. & Raabe, H. (2001). Prediction of ocular irritancy of prototype shampoo formulations by the isolated rabbit eye (IRE) test and the bovine corneal opacity and permeability (BCOP) assay. Toxicology in Vitro 15, 95-103.
66. ECVAM (2000). Preliminary Evaluation of the Application of Reference Standards in the Prevalidation and Validation of In Vitro Tests for Eye Irritation. Final report from TNO BIBRA to ECVAM. TNO BIBRA Report No. 2/3387/00. ECVAM contract no. 1447-1998-11 FlED ISP GB. Ispra, Italy: ECVAM.
67. Worth, A.P. & Fentem, J.H. (1999). A general approach for evaluating stepwise testing strategies. ATLA 27, 161-177.
68. Fielder, R.J., Gaunt, I.F., Rhodes, C., Sullivan, F.M. & Swanston, D.W. (1987). Hierarchical approach to the assessment of dermal and ocular irritancy: a report by the British Toxicology Society working party on irritancy. Human and Experimental Toxicology 6, 269-278.
69. Cejkova, J., Lojda, Z., Brunova, B., Vacik, J. & Michalek, J. (1988). Disturbances in the rabbit cornea after short-term and long-term wear of hydrogel contact lenses: usefulness of histochemical methods. Histochemistry 89, 91-97.
70. Ubels, J.L., Prius, R.M., Sybesma, J.T. & Casterton, P.L. (2000). Corneal opacity, hydration and endothelial morphology in the cornea opacity and permeability assay using reduced treatment times. Toxicology in Vitro 14, 379-386.
71. Nguyen, D.H., Beuerman, R.W., De Wever, B. & Rosdy, M. (2003). Three-dimensional construct of the human corneal epithelium for in vitro toxicology. In Alternative Toxicological Methods (ed. H. Slaem & S.A. Katz), pp. 147-159. Boca Raton, FL, USA: CRC Press.
72. Atterwill, C.K., Bruinink, A., Drejer, J., Duarte, E., McFarlane Abdulla, E., Meredith, C., Nicotera, P., Regan, C., Rodrigues-Farre, E., Simpson, M.G., Smith, R., Veronesi, B., Vijverberg, H., Walum, E. & William, C.D. (1994). In vitro neurotoxicity testing. The report and recommendations of ECVAM workshop 3. ATLA 22, 350-362.
73. Pentreath, V.W., ed. (1999). Neurotoxicology In Vitro, 291pp. London, UK: Taylor & Francis.
74. Atterwill, C.K. & Purcell, W.M. (1999). Brain spheroid and other organotypic culture systems in in vitro neurotoxicology. In Neurotoxicology In Vitro (ed. V.W. Pentreath), pp. 213-238. London, UK: Taylor & Francis.
75. Purcell, W.M., Atterwill, C.K. & Xu, J. (2003). Cryopreservation of organotypic brain spheroid cultures. ATLA 31, 563-573.
76. Williams, S.P., O'Brien, S., Whitmore, K., Purcell, W.H., Cookson, M.R., Mead, C., Pentreath, V.W. & Atterwill, C.K. (1996). An in vitro neurotoxicity testing scheme: evaluation of cytotoxicity determinations in neural and non-neural cells. In Vitro Toxicology 9, 83-92.
77. Fielder, R., Atterwill, C.K., Anderson, D., Boobis, A.R., Botham, P., Chamberlain, M., Combes, R., Duffey, P.A., Lewis, R.W., Lumley, C.E., Kimber, I. & Newall, D.R. (1997). British Toxicology Society (BTS) working party report on in vitro toxicology. Human and Experimental Toxicology 16, S1-S40.
78. Balls, M. & Walum, E. (1999). Towards the acceptance of in vitro neurotoxicity tests. In Neurotoxicology In Vitro (ed. V.W. Pentreath), pp. 26-28. London, UK: Taylor & Francis.
79. Guillouzo, A. (1997). Biotransformation of drugs by hepatocytes. In In Vitro Methods in Pharmaceutical Research (ed. J.V. Castell & M.J. Gómez-Lechón), pp. 411-432. London, UK: Academic Press.
80. Gómez-Lechón, M.J., Donato, T., Ponsoda, X. & Castell, J.V. (2003). Human hepatic cell cultures: in vitro and in vivo drug metabolism. ATLA 31, 257-266.
81. DeJongh, J., Forsby, A., Houston, J.B., Beckman, M., Combes, R. & Blaauboer, B.J. (1999). An integrated approach to the prediction of systemic toxicity using computer-based biokinetic models and biological in vitro test methods: overview of a prevalidation study based on the ECITTS project. Toxicology in Vitro 13, 549-554.
82. Blaauboer, B.J. (2003). Biokinetic and toxicodynamic modelling and its role in toxicological research and risk assessment. ATLA 31, 277-282.
83. Bruce, R.D. (1985). An up-and-down procedure for acute toxicity testing. Fundamental and Applied Toxicology 5, 151-157.
84. Van den Heuvel, M.J., Clark, D.G., Fielder, R.J., Koundakjian, P.P., Oliver, G.J.A., Pelling, D., Tomlinson, N.J. & Walker, A.P. (1990). The international validation of a fixed-dose procedure as an alternative to the classical LD50 test. Food and Chemical Toxicology 28, 469-482.
85. Stallard, N. & Whitehead, A. (1995). The fixed-dose procedure and the acute-toxic-class method: a mathematical comparison. Human and Experimental Toxicology 14, 974-990.
86. OECD (1996). OECD Guidelines for the Testing of Chemicals, No. 423: Acute Oral Toxicity - Acute Toxic Class Method, 15pp. Paris, France: OECD.
87. Stallard, N., Whitehead, A. & Indans, I. (2003). Statistical evaluation of the fixed concentration procedure for acute inhalation toxicity assessment. Human and Experimental Toxicology 22, 575-585.
88. Lipnick R.L., Cotruvo, J.A., Hill, R.N., Bruce, R.D., Stitzel, K.A., Walker, A.P., Chu, I., Goddard, M., Segal, L., Springer, J.A. & Myers, R.C. (1995). Comparison of the up-and-down, conventional LD50, and fixed-dose acute toxicity procedures. Food and Chemical Toxicology 33, 223-231.
89. Ekwall, B. (1999). Overview of the final MEIC results. II. The in vitro-in vivo evaluation, including the selection of a practical battery of cell tests for prediction of acute lethal blood concentrations in humans. Toxicology in Vitro 13, 665-673.
90. Botham, P.A. (2004). Acute systemic toxicity - prospects for tiered testing strategies. Toxicology in Vitro 18, 227-230.
91. Spielmann, H., Genschow, E., Liebsch, M. & Halle, W. (1999). Determination of the starting dose for acute oral toxicity (LD50) testing in the Up-and-Down Procedure (UDP) from cytotoxicity data. ATLA 27, 957-966.
92. NIH (2001). Report of the International Workshop on In Vitro Methods for Assessing Acute Systemic Toxicity, 158pp. Research Triangle Park, NC, USA: NIEHS.
93. NIH (2001). Guidance Document on Using In Vitro Data to Estimate In Vivo Starting Doses for Acute Toxicity. NIH Publication No. 01-4500, 24pp. Research Triangle Park, NC, USA: NIEHS. Website http://iccvam.niehs.nih.gov (Accessed 1.9.04).
94. Basketter, D.A., Lea, L.J., Cooper, K., Stocks, J., Dickens, A., Pate, I., Dearman, R.J. & Kimber, I. (1999). Threshold for classification as a skin sensitizer in the local lymph node assay: a statistical evaluation. Food and Chemical Toxicology 37, 1-8.
95. ICCVAM (1999). The Murine Local Lymph Node Assay: A Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals/Compounds. NIH Publication No. 99-4494, 45pp. Research Triangle Park, NC, USA: NIEHS. Website http://iccvam.niehs.nih.gov (Accessed 7.8.02).
96. Haneke, K.E., Tice, R.R., Carson, B.L., Margolin, B.H. & Stokes, W.S. (2001). ICCVAM evaluation of the murine local lymph node assay. III. Data analyses completed by the National Toxicology Program Interagency Center for Evaluation of Alternative Toxicological Methods. Regulatory Toxicology and Pharmacology 34, 274-286.
97. ECVAM (2000). Statement on the validity of the local lymph node assay for skin sensitisation testing. ATLA 28, 366-367.
98. Pazos, P., Fortana, S. & Prieto, P. (2002). Long-term in vitro toxicity models: comparisons between a flow-cell bioreactor, a static-cell bioreactor and static cell cultures. ATLA 30, 515-523.
99. Pfaller, W., Balls, M., Clothier, R., Coecke, S., Dierickx, P., Ekwall, B., Hanley, B.A., Hartung, T., Prieto, T., Ryan, M.P., Schmuck, G., Sladowski, D., Vericat, J-A., Wendel, A., Wolf, A. & Zimmer, J. (2001). Novel advanced in vitro methods for long-term toxicity testing. The report and recommendations of ECVAM workshop 45. ATLA 29, 393-426.
100. Jennings, P., Koppelstaetter, C., Pfaller, W., Morin, J-P., Hartung, T. & Ryan, M.P. (2004). Assessment of a new cell culture perfusion apparatus for in vitro chronic toxicity testing. Part 2. Toxicological evaluation. ALTEX 21, 61-66.
101. Broadhead, C.L., Betton, G., Combes, R., Damment, S., Everett, D., Garner, C., Godsafe, Z., Healing, G., Heywood, R., Jennings, M., Lumley, C., Oliver, G., Smith, D., Straughan, D., Topham, J., Wallis, R., Wilson, S. & Buckley, P. (observer) (2000). Prospects for reducing and refining the use of dogs in regulatory toxicity testing of pharmaceuticals. Human and Experimental Toxicology 19, 440-447.
102. Morton, D.B., Hawkins, P., Bevan, R., Heath, K., Kirkwood, J., Pearce, P., Scott, L., Whelan, G. & Webb, A. (2003). Refinements in telemetry procedures. Seventh report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement, Part A. Laboratory Animals 37, 261-299.
103. Hawkins, P., Morton, D.B., Bevan, R., Heath, K., Kirkwood, J., Pearce, L., Scott, G., Whelan, G. & Webb, A. (2004). Husbandry requirements for rats, mice, dogs and non-human primates used in telemetry procedures. Seventh Report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement, Part B. Laboratory Animals 38, 1-10.
104. Smith, D., Broadhead, C., Descotes, G., Fosse, R., Hack, R., Krauser, K., Pfister, R., Phillips, B., Rabemampianina, Y., Sanders, J., Sparrow, S., Stephan-Gueldner, M. & Jacobsen, S.D. (2002). Preclinical safety evaluation using nonrodent species: an industry/welfare project to minimize dog use. ILAR Journal 43, Suppl., S39-S42.
105. Green, S., Goldberg, A. & Zurlo, J. (2001). TestSmart-high production volume chemicals: an approach to implementing alternatives into regulatory toxicology. Toxicological Sciences 63, 6-14.
106. Thomas, R.S., Rank, D.R., Penn, S.G., Zastrow, G.M., Hayes, K.R., Pande, K., Glover, E., Silander, T., Craven, M.W., Reddy, J.K., Jovanovich, S.B. & Bradfield, C.A. (2001). Identification of toxicologically predictive gene sets using cDNA microarrays. Molecular Pharmacology 60, 1189-1194.
107. Jenkins, E.S., Broadhead, C. & Combes, R.D. (2002). The implications of microarray technology for animal use in scientific research. ATLA 30, 459-465.
108. Fry, J. & George, E. (2001). In vitro toxicology in the light of new technologies. ATLA 29, 745-748.
109. Lumley, C.E. & van Cauteren, H. (1997). Harmonisation of international toxicity testing guidelines for pharmaceuticals: contribution to refinement and reduction in animal use. European Biomedical Research Association Bulletin, November 1997, 4-9.
110. Combes, R.D. (1995). Regulatory genotoxicity testing: a critical appraisal. ATLA 23, 352-379.
111. Combes, R.D. (1997). Detection of nongenotoxic carcinogens: major barriers to replacement of the rodent bioassay? In Animal Alternatives, Welfare and Ethics (ed. L.F.M. van Zutphen & M. Balls), pp. 627-634. Oxford, UK: Elsevier.
112. Combes, R.D. (2000). The use of structure-activity relationships and markers of cell toxicity to detect non-genotoxic carcinogens. Toxicology in Vitro 14, 387-399.
113. ICH (1997). Genotoxicity: Standard Battery of Tests. Report of Fourth International Conference on Harmonisation, Brussels, July 1997. Step 4 report. Brussels, Belgium: ICH.
114. Tennant, R.W., Stasiewicz, S., Mennear, J., French, J.E. & Spalding, J.W. (1999). Genetically altered mouse models for identifying carcinogens. In The Use of Short- and Medium-Term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation (ed. D.B. McGregor, J.M. Rice & S. Venitt), pp. 123-150. Lyon, France: IARC.
115. van Zeller, A-M. & Combes, R.D. (1999). Transgenic mouse bioassays for carcinogenicity testing: a step in the right direction? ATLA 27, 839-846.
116. Anon. (2001). An evaluation of alternatives to carcinogenicity testing. Toxicologic Pathology 29, S5.
117. Battershill, J.M. & Fielder, R.J. (1998). Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogen bioassays in transgenic mice. Human and Experimental Toxicology 17, 193-205.
118. Pritchard, J.B., French, J.E., Davis, B.J. & Haseman, J.K. (2003). The role of transgenic mouse models in carcinogen identification. Environmental Health Perspectives 111, 444-454.
119. Combes, R., Balls, M., Curren, R., Fischbach, M., Fusenig, N., Kirkland, D., Lasne, C., Landolph, J., LeBoeuf, R., Marquardt, H., McCormick, J., Müller, L., Rivedal, E., Sabbioni, E., Tanaka, N., Vasseur, P. & Yamasaki, H. (1999). Cell transformation assays as predictors of human carcinogenicity. The report and recommendations of ECVAM workshop 39. ATLA 27, 745-767.
120. OECD (2003). Detailed review paper on non-genotoxic carcinogens detection: the performance of in vitro cell transformation assays. OECD Environmental Health and Safety Publications: Series on Testing and Assessment, No. 31, 72pp. Paris, France, OECD.
121. Engelhardt, G., Schwind, K-R. & Mussler, B. (2004). The testing of chemicals in the Syrian hamster embryo (SHE) cell transformation assay for assessment of carcinogenic potential. Toxicology in Vitro 18, 213-218.
122. Tsuchiya, T., Umeda, M., Nishiyama, H., Yoshimura, I., Ajimi, S., Asakura, M., Baba, H., Dewa, Y., Ebe, Y., Fushiwaki, Y., Hamada, S., Hamamura, T., Hayashi, M., Iwase, Y., Kajiwara, Y., Kasahara, Y., Kawabata, M., Kitada, E., Kubo, K., Mashiko, K., Miura, D., Mizuhashi, F., Mizuno, F., Nakajima, M., Nakamura, Y., Nobe, N., Oishi, H., Ota, E., Sakai, A., Sato, M., Shimada, S., Sugiyama, T., Takahashi, C., Takeda, Y., Tanaka, N., Toyoizumi, C., Tsutsui, T., Wakuri, S., Yajima, S. & Yajima, N. (1999). An interlaboratory validation study of the improved transformation assay employing Balb/c 3T3 cells: results of a collaborative study on the two-stage cell transformation assay by the Non-genotoxic Carcinogen Study Group. ATLA 27, 685-702.
123. Butterworth, B.E., Connolly, R.B. & Morgan, K.T. (1995). A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments. Cancer Letters 93, 129-146.
124. Phillips, J.C. & Gangolli, S.D. (1993). Theory and practice in metabolic studies. In Experimental Toxicology: The Basic Issues, 2nd edn (ed. D. Anderson & D.M. Conning), pp. 181-201. London, UK: Royal Society of Chemistry.
125. Home Office (2004). Animal (Scientific Procedures) Act 1986: Guidance on the Conduct of Regulatory Toxicology and Safety Evaluation Studies. Website http://www.homeoffice. gov.uk/docs/supp_regtox. html (Accessed 23.7.04).
126. Dean, S.W. (1999). Environmental enrichment of laboratory animals used in toxicity studies. Laboratory Animals 33, 309-327.
127. Hubrecht, R. (1995). Dogs and dog housing. In Environmental Enrichment Information Resources for Laboratory Animals: 1965-1995: Birds, Cats, Dogs, Farm Animals, Ferrets, Rabbits and Rodents (ed. C.P. Smith & V. Taylor), AWIC Resource Series No. 2, pp. 49-62. Beltsville, MD, USA: US Department of Agriculture and Potters Bar, UK: Universities Federation for Animal Welfare.
128. Morton, D.B. (2002). The importance of non-statistical experimental design in refining animal experiments for scientists, IACUCs, and other ethical review panels. In Applied Ethics in Animal Research: Philosophy, Regulation, and Laboratory Applications (ed. J.P. Gluck, A. DiPasquale & F.B. Orlans), pp. 149-178. West Lafayette, IN, USA: Purdue University Press.
129. Combes, R.D., Berridge, T., Connelly, J., Eve, M.D., Garner, R.C., Toon, S. & Wilcox, P. (2003). Early microdose drug studies in human volunteers can minimise animal testing. Proceedings of a workshop organised by volunteers in research and testing. European Journal of Pharmaceutical Sciences 19, 1-11.
130. Cronin, M.T.D., Jaworska, J.S., Walker, J.D., Comber, M.H.I., Watts, C.D. & Worth, A.P. (2003). Use of QSAEs in international decision-making frameworks to predict health effects of chemical substances. Environmental Health Perspectives 111, 1391-1401.
131. OECD (1996). OECD Guidelines for the Testing of Chemicals, No. 422: Combined Repeated Dose Toxicity Study with the Reproduction/Development Toxicity Screening Test, 14pp. Paris, France: OECD.
132. Sauer, U.G. (2004). Avoidance of animal experiments in the new EU chemicals regulation-opportunities and problems from the point of view of animal welfare. ALTEX 21, 9-14.
133. Tichias, K., Fentem, J., Basketter, D., Botham, P., Brooker, P., Bruner, L., Evans, P., Fairhurst, S., Fassold, E., Fielder, R., Gerberick, F., Harvey, P., Koëter, H., Parsons, P., Schlede, E., Shannon, D. & Spielmann, H. (1998). Progress in toxicological testing: reduction and refinement issues. Recommendations from a joint UK Government/ECVAM meeting. ATLA 26, 619-627.
134. Gerner, I., Graetschel, G., Kahl, J. & Schlede, E. (1999). Development of a decision support system for the introduction of alternative methods into local irritancy/corrosivity testing strategies. Development of a relational database. ATLA 28, 11-28.
135. Zinke, S., Gerner, I. & Schlede, E. (2002). Evaluation of a rule base for identifying contact allergens by using a regulatory database: comparison of data on chemicals notified in the European Union with "structural alerts" used in the DEREK expert system. ATLA 30, 285-298.
136. Combes, R.D. (1999). New measures on animal experimentation in the UK will improve animal welfare and scientific research. ATLA 27, 309-316.
137. Close, B., Banister, K., Baumans, V., Bernoth, E.M., Bromage, N., Bunyan, J., Erhardt, W., Flecknell, P., Gregory, N., Hackbarth, H., Morton, D. & Warwick, C. (1996). Recommendations for euthanasia of experimental animals: Part 1. DGXI of the European Commission. Laboratory Animals 30, 293-316.
138. Close, B., Banister, K., Baumans, V., Bernoth, E.M., Bromage, N., Bunyan, J., Erhardt, W., Flecknell, P., Gregory, N., Hackbarth, H., Morton, D. & Warwick, C. (1997). Recommendations for euthanasia of experimental animals: Part 2. DGXI of the European Commission. Laboratory Animals 31, 1-32.
139. Morton, D.B. & Griffiths, P.H.M. (1985). Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Veterinary Record 116, 431-436.
140. Robinson, V., Morton, D.B., Anderson, D., Carver, J.F.A., Francis, R.J., Hubrecht, R., Jenkins, E., Mathers, K.E., Raymond, R., Rosewell, I., Wallace, J. & Wells, D.J. (2003). Refinement and reduction in production of genetically modified mice. Sixth Report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement. Laboratory Animals 37, Suppl. 1, S1-S51.
141. Brown, A.P. & Levine, B.S. (1999). Relationship Between Dosing Vehicles, Dose Volume, and Stress. Report Prepared for the US National Toxicology Program, 24pp. Website http://www.hsus.org/ace/11443 (Accessed 24.8.04).
142. Combes, R.D. (2003). A critical assessment of the OECD collaborative study to validate the uterotrophic assay for the detection of oestrogenic and anti-oestrogenic chemicals. ATLA 31, 489-499.
143. Morton, D.B., Jennings, M., Buckwell, A., Ewbank, R., Godfrey, C., Holgate, B., Inglis, I., James, R., Page, C., Sharman, I., Vershoyle, R., Westall, L. & Wilson, A.B. (2001). Refining procedures for the administration of substances. Laboratory Animals 35, 1-41.
144. LASA (1998). LASA Good Practice Guidelines Series 1, Issue 1. Administration of Substances. Tamworth, UK: Laboratory Animal Science Association.
145. Bottrill, K. (1998). The use of biomarkers as alternatives to current animal tests on food chemicals. ATLA 26, 421-480.
146. Combes, R.D. (2000). Endocrine disruptors: a critical review of in vitro and in vivo testing strategies for assessing their toxic hazard to humans. ATLA 28, 81-118.
147. Anon. (1987). Council Directive 87/18/EEC of 18 December 1986 on the harmonisation of laws, regulations and administrative provisions relating to the application of the principles of good laboratory practice and the verification of their applications for tests on chemical substances. Official Journal of the European Communities L015, 29-30.
148. Anon. (1986). Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official Journal of the European Communities L358, 1-29.